Literature DB >> 6786458

Inheritance of abnormal erythrocyte cation transport in essential hypertension.

P Meyer, R P Garay, C Nazaret, G Dagher, M Bellet, M Broyer, J Feingold.   

Abstract

Net fluxes of sodium and potassium ions were determined in sodium-loaded, potassium-depleted erythrocytes from 370 white subjects, 194 of whom had essential hypertension or had been born to parents with essential hypertension. Findings were compared with those in 86 controls who were normotensive and did not have a family history of hypertension. Compared with controls all patients with essential hypertension had a low sodium to potassium ratio secondary to a deficit in the sodium-potassium cotransport system. A similar abnormality was found in subjects born to parents with essential hypertension, the prevalences of a deficient cotransport system in such subjects being 53.6% (52 out of 97) among those with one hypertensive parent and 73.7% (14 out of 19) among those with two hypertensive parents. Both sexes were equally affected. Studies in 14 families over two or three generations showed the erythrocyte cation abnormality in one or more members of each consecutive generation. No close association was evident between the deficient erythrocyte sodium-potassium cotransport system and either blood groups ABO, Rh, Kidd, Duffy, P, and MNS or the major histocompatibility HLA antigens. Out of 90 consecutive unrelated and normotensive white blood donors, 36 showed a low erythrocyte sodium-potassium net flux ratio. It is concluded that in white people abnormal erythrocyte cation transport is a biochemical disorder characteristic of essential hypertension and transmitted by a dominant and autosomal mode expressing a single abnormal gene.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786458      PMCID: PMC1505030          DOI: 10.1136/bmj.282.6270.1114

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Sequential tests for the detection of linkage.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1955-09       Impact factor: 11.025

2.  Association of blood groups with essential and secondary hypertension. A possible association of the MNS system.

Authors:  J Z Miller; C E Grim; P M Conneally; M H Weinberger
Journal:  Hypertension       Date:  1979 Sep-Oct       Impact factor: 10.190

Review 3.  Hypertension in the pediatric patient: a reappraisal.

Authors:  J M Loggie; M I New; A M Robson
Journal:  J Pediatr       Date:  1979-05       Impact factor: 4.406

4.  HLA antigens in essential hypertension. Relation to familiar disposition and serum immunoglobulins.

Authors:  B O Kristensen; P L Andersen; L U Lamm; F Kissmeyer-Nielsen
Journal:  Tissue Antigens       Date:  1977-08

5.  Increased sodium-lithium countertransport in red cells of patients with essential hypertension.

Authors:  M Canessa; N Adragna; H S Solomon; T M Connolly; D C Tosteson
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

6.  Abnormal biochemistry of vascular smooth muscle plasma membrane isolated from hypertensive rats.

Authors:  C Y Kwan; L Belbeck; E E Daniel
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

Review 7.  Interaction of environmental factors and systemic arterial blood pressure: a review.

Authors:  M C Gutmann; H Benson
Journal:  Medicine (Baltimore)       Date:  1971-11       Impact factor: 1.889

8.  Inherited defect in a Na+, K-co-transport system in erythrocytes from essential hypertensive patients.

Authors:  R P Garay; G Dagher; M G Pernollet; M A Devynck; P Meyer
Journal:  Nature       Date:  1980-03-20       Impact factor: 49.962

9.  Laboratory distinction between essential and secondary hypertension by measurement of erythrocyte cation fluxes.

Authors:  R P Garay; J L Elghozi; G Dagher; P Meyer
Journal:  N Engl J Med       Date:  1980-04-03       Impact factor: 91.245

10.  A new test showing abnormal net Na+ and K+ fluxes in erythrocytes of essential hypertensive patients.

Authors:  R P Garay; P Meyer
Journal:  Lancet       Date:  1979-02-17       Impact factor: 79.321

View more
  12 in total

1.  Predicting and preventing hypertension and associated cardiovascular disease.

Authors:  S W Rabkin
Journal:  Can Fam Physician       Date:  1985-02       Impact factor: 3.275

2.  Influence of dietary linoleic acid on leucocyte sodium transport and blood pressure.

Authors:  A M Heagerty; J D Ollerenshaw; D I Robertson; R F Bing; J D Swales
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-02

3.  Role of the furosemide-sensitive Na+/K+ transport system in determining the steady-state Na+ and K+ content and volume of human erythrocytes in vitro and in vivo.

Authors:  J Duhm; B O Göbel
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

4.  New evidence linking salt and hypertension.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-20

5.  Dietary sodium and arterial pressure: problems of studies within a single population.

Authors:  G C Watt; C J Foy
Journal:  J Epidemiol Community Health       Date:  1982-09       Impact factor: 3.710

Review 6.  Blood type biochemistry and human disease.

Authors:  D Rose Ewald; Susan C J Sumner
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-09-07

7.  Red cell membrane sodium transport: possible genetic role and use in identifying patients at risk of essential hypertension.

Authors:  J E Deal; V Shah; G Goodenough; M J Dillon
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

8.  Cellular mechanisms in hypertension and therapeutic implications in blacks.

Authors:  E Saunders
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

9.  [Blood pressure, renin angiotensin aldosterone system and other cardiovascular risk factors in children of essential hypertensives (author's transl)].

Authors:  A Studer; T Lüscher; P Greminger; F H Epstein; J Grimm; E P Leumann; W Tenschert; W Siegenthaler; W Vetter
Journal:  Klin Wochenschr       Date:  1982-03

10.  [Cation flux in erythrocytes of patients with essential hypertension].

Authors:  K H Gless; U Roelcke; W Fiehn; J F Mann; K Schaz; U Sütterlin; G A Speck
Journal:  Klin Wochenschr       Date:  1983-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.